TLDR 5-ARI therapy may help prevent prostate cancer progression.
The study discussed the use of 5-alpha reductase inhibitors (5-ARIs) in men undergoing active surveillance for low-risk prostate cancer (PCa), which had been controversial. It provided evidence suggesting that 5-ARI therapy could be beneficial, aligning with the REDEEM trial findings. Specifically, 75% of men receiving 5-ARI showed no evidence of pathologic cancer progression at the restaging biopsy after a median follow-up of 35 months.
January 2024 in “Brazilian Journal of Hair Health” Some plant-based products might treat hair loss with fewer side effects than current medications.
June 2023 in “Clinica Chimica Acta” Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.
January 2018 in “Surgical and Cosmetic Dermatology” 5-alpha reductase inhibitors like finasteride and dutasteride are effective for treating enlarged prostate and male pattern hair loss.
27 citations
,
March 2017 in “Current Clinical Pharmacology” Dutasteride is becoming a popular hair loss treatment, proving more effective than finasteride with similar side effects.
August 2016 in “Journal of Investigative Dermatology” April 2013 in “The FASEB Journal”